Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Feb 2024 for Lucid Diagnostics Inc.. Read the official filing
Filing timeline
BuySalePAVmed Inc.
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-64.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
PAVmed Inc.: trading record in brief
PAVmed Inc. is a declared insider of Lucid Diagnostics Inc., with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 18 October 2021 to 15 February 2024.
No open-market sale appears; the market trades are 1 purchase worth €6.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 20 February 2024, reports a transaction in Lucid Diagnostics Inc. The latest purchase dates back some time: it was published 1,824 days ago, on 20 October 2021. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to PAVmed Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
3,331,747 sharesCommon StockSEC:0001062993-24-003693:0
3,331,771 shares@ US$1.403319.4% of flowCommon StockSEC:0001062993-24-001613:0
1,145,086 shares@ US$1.83839.2% of flowCommon stockSEC:0001062993-23-009156:0
1,145,086 shares@ US$1.83839.2% of flowCommon stockSEC:0001062993-22-023250:0
571,428 shares@ US$14.0052.0% of flowCommon stockSEC:0001062993-21-009743:0
Canonical exit: 16 Jan 2022 (T+90)
5 of 5 declarations
